The advertisement promotes Nucala (mepolizumab) as a treatment for patients aged 6 and older with severe eosinophilic asthma, highlighting its specific use and safety information.
Creative Information
| CID: | e141f4f1-c248-4185-82b3-46f8b13961ca |
| CRID: | 82_2108-910318 |
| Domain: | nucalahcp.com |
| Seat: | PP |
| Size: | 300x250 |
| Bid: | $15.89 |
| Timestamp: | 11/10/2025, 6:36:36 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 11/10/2025, 6:49:19 PM | 6.00s | |
| adomain_analysis | success | 11/10/2025, 8:29:07 PM | 3.04s | |
| adomain_capture | success | 11/10/2025, 8:29:04 PM | 0.10s | |
| ad_render | success | 11/10/2025, 6:49:13 PM | 25.34s | |
| brand_mapping | success | 11/10/2025, 6:36:36 PM | 0.10s | |
Analysis Results
Ad Format: banner
Brands: NUCALA
Sensitive:Pharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 300x250 | ||||||||||||||||||||||
| Data Transferred: | 1670.63 KB | ||||||||||||||||||||||
| Render Time: | 9.81 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 1691.79 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives

